No label defined (Q31256)
Jump to navigation
Jump to search
No description defined
- Testosterone and other treatments for transgender males and non-binary trans masculine individuals.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | No label defined |
No description defined |
|
Statements
Testosterone therapy is the main hormonal treatment offered in transmen to alleviate somatic gender dysphoria. (English)
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
2024
Testosterone can be administered via topical or injectable preparations to achieve physical changes resulting in masculinisation and improve quality of life for the treated individuals. (English)
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
2024
The aim of our paper is to outline methods for testosterone replacement, their impact on main body systems of transmen, potential associated health risks and long term follow up. (English)
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
2024
Androgen use in transgender medicine is safe with appropriate endocrine guidance and monitoring. (English)
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
2024
Studies with longer follow-up period, including those who may prefer low dose testosterone, interested in pregnancy or older people may further improve the management of female-to-male transgender persons. (English)
Copyright © 2024 The Authors. Published by Elsevier Ltd.. All rights reserved. (English)
2024
A (English)
Dimakopoulou (English)
A
13 September 2024
13 September 2024
Declaration of Competing Interest The authors declare no conflict of interest, financial or otherwise. (English)